Baku 10° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
09:08
Key indicators of world commodity, stock, and currency markets (09.01.2026)
Finance09:00
Musk's X could be banned in Britain over AI chatbot row
Other countries08:50
Trump says he may meet with Venezuelan opposition politician Machado soon
Other countries08:41
NASA chief says Crew-11 mission crew to return from ISS to Earth ahead of schedule
Other countries08:32
Iran president calls for 'utmost restraint' in handling protests
Region08:23
Russian strikes plunge Ukraine's industrial southeast into blackouts
Other countries08:15
EU considering possible response to Trump's threats against Greenland — Kallas
Other countries08:05
Trump does not intend to pardon Maduro — NYT
Other countries20:57